Christopher J. Lindop, CFO & Vice President of at HAEMONETICS CORP (HAE), sold 61,783 shares at $75.00 ($4.6M) on 2012-09-04, disclosed to the SEC on 2012-09-06.
Scheduled sale ($4.6M) by CFO & Vice President of under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.00 | 40,545 | $3.0M | 65.3% |
| 2 | $75.00 | 21,238 | $1.6M | 34.7% |
| Total | $74.34 avg | 61,783 | $4.6M | 100% |
| Filing → |
| HAE | SELL | 2015-08-24 | $189K | — | Filing → |
| HAE | SELL | 2015-07-21 | $192K | — | Filing → |
| HAE | SELL | 2015-06-23 | $208K | — | Filing → |